iodixanol and sulfasalazine

iodixanol has been researched along with sulfasalazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Braza, F; Filipovic, Z; Kerr, SW; Nodop, SG; Noonan, TC; Winquist, RJ; Wolyniec, WW	1

Other Studies

2 other study(ies) available for iodixanol and sulfasalazine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2 Topics: Animals; Biomarkers; Colitis; Colon; Contrast Media; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Feces; HLA-B27 Antigen; Humans; Inflammation; Intestinal Mucosa; Leukocytes, Mononuclear; Male; Organ Size; Permeability; Rats; Rats, Inbred F344; Rats, Mutant Strains; Sulfasalazine; Time Factors; Triiodobenzoic Acids	1999

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.

The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2

Topics: Animals; Biomarkers; Colitis; Colon; Contrast Media; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Feces; HLA-B27 Antigen; Humans; Inflammation; Intestinal Mucosa; Leukocytes, Mononuclear; Male; Organ Size; Permeability; Rats; Rats, Inbred F344; Rats, Mutant Strains; Sulfasalazine; Time Factors; Triiodobenzoic Acids

1999